Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities. (Record no. 26479665)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02228 a2200589 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517120429.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201801s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1091-6490 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1073/pnas.1611421113 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Subudhi, Sumit K |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180129 |
| 245 00 - TITLE STATEMENT | |
| Title | Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Proceedings of the National Academy of Sciences of the United States of America |
| Date of publication, distribution, etc. | 10 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 11919-11924 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents, Immunological |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomarkers |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CD8-Positive T-Lymphocytes |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical Trials, Phase II as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clonal Evolution |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Susceptibility |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug-Related Side Effects and Adverse Reactions |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ipilimumab |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphocyte Count |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prostatic Neoplasms |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Severity of Illness Index |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | T-Lymphocyte Subsets |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aparicio, Ana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gao, Jianjun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zurita, Amado J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Araujo, John C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Logothetis, Christopher J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tahir, Salahaldin A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Korivi, Brinda R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Slack, Rebecca S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vence, Luis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Emerson, Ryan O |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yusko, Erik |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vignali, Marissa |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Robins, Harlan S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sun, Jingjing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Allison, James P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sharma, Padmanee |
| 773 0# - HOST ITEM ENTRY | |
| Title | Proceedings of the National Academy of Sciences of the United States of America |
| Related parts | vol. 113 |
| -- | no. 42 |
| -- | p. 11919-11924 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1073/pnas.1611421113">https://doi.org/10.1073/pnas.1611421113</a> |
| Public note | Available from publisher's website |
No items available.